Global Pneumonia Testing Market 2017-2021 - Product Image

Global Pneumonia Testing Market 2017-2021

  • ID: 4115315
  • Report
  • Region: Global
  • 117 pages
  • TechNavio
OFF
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

1 of 5

FEATURED COMPANIES

  • Abbott Molecular
  • Beckman Coulter
  • Bio-Rad
  • Diamedix
  • Fast-track diagnostics
  • Qiagen
  • MORE
About Pneumonia Testing

Pneumonia is a complicated infection of the lower respiratory tract. It may start on or after an upper respiratory tract infection. Mostly, it affects people with weakened immune systems and is common in children and older people.

The analysts forecast the global pneumonia testing market to grow at a CAGR of 9.91% during the period 2017-2021.

Covered in this report
The report covers the present scenario and the growth prospects of the global pneumonia testing market for 2017-2021. To calculate the market size, the report considers the revenue generated from the sales of various diagnostic tests for pneumonia (community-acquired pneumonia (CAP) and hospital-acquired pneumonia (HAP)) to key end-users such as hospitals, diagnostic laboratories, and homecare.

The market is divided into the following segments based on geography:
- Americas
- APAC
- EMEA

The report, Global Pneumonia Testing Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the Key vendors operating in this market.

Key vendors
- Abbott Molecular
- bioMérieux
- Becton, Dickenson and Company (BD)
- Roche Molecular Diagnostics
- Thermo Fisher Scientific

Other prominent vendors
- AdvanDx
- Alere
- Beckman Coulter
- Bio-Rad
- Cepheid
- Concile
- Diamedix
- DiaSorin
- Eiken Chemical
- Fast-track diagnostics
- Hologic
- Meridian Biosciences
- Qiagen
- Quest Diagnostics
- Quidel
- SeraCare
- Trinity Biotech

Market drivers
- Increased awareness regarding early diagnosis and preventive measures.
- For a full, detailed list, view the full report

Market challenges
- Limited detection capability and accuracy.
- For a full, detailed list, view the full report

Market trends
- Growing consumer shift toward direct-to-consumer testing.
- For a full, detailed list, view the full report

Key questions answered in this report
- What will the market size be in 2021 and what will the growth rate be?
- What are the key market trends?
- What is driving this market?
- What are the challenges to market growth?
- Who are the key vendors in this market space?
- What are the market opportunities and threats faced by the key vendors?
- What are the strengths and weaknesses of the key vendors?

You can request one free hour of the analyst’s time when you purchase this market report. Details are provided within the report.
READ MORE
Note: Product cover images may vary from those shown
2 of 5

FEATURED COMPANIES

  • Abbott Molecular
  • Beckman Coulter
  • Bio-Rad
  • Diamedix
  • Fast-track diagnostics
  • Qiagen
  • MORE
PART 01: Executive summary

PART 02: Scope of the report

Market overview

Top-vendor offerings

PART 03: Market research methodology

Research methodology

Economic indicators

PART 04: Introduction

Key market highlights

Pneumonia: An overview

Market snapshot

PART 05: Market landscape

Market overview

Market size and forecast

Buying criteria

Five forces analysis

PART 06: Market segmentation by product type

Global pneumonia testing market by analyzers

Global pneumonia testing market by consumables

PART 07: Market segmentation by method

Immunodiagnostics

Molecular diagnostics

POC

Global pneumonia testing market by immunodiagnostics

Global pneumonia testing market by molecular diagnostics

Global pneumonia testing market by POC

PART 08: Market segmentation by technology

ELISA

Immunofluorescence

Western blot

PCR

IHC

NASBA

Others

PART 09: Market segmentation by end-user

Hospitals

Diagnostic laboratories

Homecare

Others

PART 10: Geographical segmentation

Pneumonia testing market in the Americas

Pneumonia testing market in EMEA

Pneumonia testing market in APAC

PART 11: Market drivers

Increased awareness regarding early diagnosis and preventive measures

Growing popularity of POC testing

Marketing strategies of vendors

Improvement in healthcare infrastructure

PART 12: Impact of drivers

PART 13: Market challenges

Limited detection capability and accuracy

Presence of an undiagnosed population

Regulatory and economic hurdles

PART 14: Impact of drivers and challenges

PART 15: Market trends

Increase in adoption of molecular diagnostic testing

Growing consumer shift toward direct-to-consumer testing

Shift from monoplex to multiplex testing

PART 16: Vendor landscape

Competitive scenario

Market share analysis

Geographical presence of the key vendors

Key news

PART 17: Key vendor analysis

Abbott Molecular

bioMérieux

BD0

Roche Molecular Diagnostics

Thermo Fisher Scientific

Other prominent vendors

PART 18: Appendix

List of abbreviations

PART 19: About the Author

List of Exhibits
Exhibit 01: Product offerings
Exhibit 02: Global pneumonia testing market by type 2016
Exhibit 03: Global pneumonia testing market: Analysis
Exhibit 04: Yearly prevalence of pneumonia, region wise
Exhibit 05: Market overview: Global pneumonia testing market
Exhibit 06: Global pneumonia testing market 2016-2021 ($ millions)
Exhibit 07: Global pneumonia testing market analysis: Developed and emerging markets
Exhibit 08: Key buying criteria in global pneumonia testing market
Exhibit 09: Buying criteria for pneumonia testing
Exhibit 10: Five forces analysis
Exhibit 11: Global pneumonia testing market segmentation by product type 2016
Exhibit 12: Global pneumonia testing market segmentation by product type 2021
Exhibit 13: Market overview: Global pneumonia testing market by analyzers
Exhibit 14: Global pneumonia testing market by analyzers 2016-2021 ($ millions)
Exhibit 15: Market overview: Global pneumonia testing market by consumables
Exhibit 16: Global pneumonia testing market by consumables 2016-2021 ($ millions)
Exhibit 17: Segmentation of pneumonia testing market by product type 2016-2021 ($ millions)
Exhibit 18: Segmentation of global pneumonia testing market by product type 2016-2021 (%)
Exhibit 19: Global pneumonia testing market by method
Exhibit 20: Global pneumonia testing market segmentation by method 2016
Exhibit 21: Global pneumonia testing market segmentation by method 2021
Exhibit 22: Global pneumonia testing market by immunodiagnostics 2016-2021 ($ millions)
Exhibit 23: Global pneumonia testing market by molecular diagnostics 2016-2021 ($ millions)
Exhibit 24: Global pneumonia testing market by POC 2016-2021 ($ millions)
Exhibit 25: Segmentation of pneumonia testing market by method 2016-2021 ($ millions)
Exhibit 26: Segmentation of pneumonia testing market by product type 2016-2021 (%)
Exhibit 27: Global pneumonia testing market by technology
Exhibit 28: Global pneumonia testing market by technology 2016
Exhibit 29: Global pneumonia testing market segmentation by end-users 2016
Exhibit 30: Global pneumonia testing market segmentation by geography 2016
Exhibit 31: Global pneumonia testing market segmentation by geography 2021
Exhibit 32: Global pneumonia testing market: Country-wise revenue and growth analysis 2016
Exhibit 33: Global pneumonia testing market: Geography lifecycle analysis 2016
Exhibit 34: Market overview: Americas
Exhibit 35: Pneumonia testing market in Americas 2016-2021 ($ millions)
Exhibit 36: Country-wise analysis: Americas
Exhibit 37: Market overview: EMEA
Exhibit 38: Pneumonia testing market in EMEA 2016-2021 ($ millions)
Exhibit 39: Country-wise analysis: EMEA
Exhibit 40: Market overview: APAC
Exhibit 41: Pneumonia testing market in APAC 2016-2021 ($ millions)
Exhibit 42: Country-wise analysis: APAC
Exhibit 43: Global pneumonia testing market segmentation by geography 2016-2021 (%)
Exhibit 44: Global pneumonia testing market segmentation by geography 2016-2021 ($ millions)
Exhibit 45: Geographical overview: Global pneumonia testing market
Exhibit 46: Yearly country-wise death rates per 100,000 population due to pneumonia on average 2015
Exhibit 47: Marketing strategies of global vendors
Exhibit 48: Impact of drivers
Exhibit 49: Recent initiatives taken to combat antibiotic resistance
Exhibit 50: Country-wise regulatory requirements
Exhibit 51: Impact of drivers and challenges
Exhibit 52: Acquisitions by global vendors in 2016
Exhibit 53: Competitive structure analysis of global pneumonia testing market 2016
Exhibit 54: Market penetration of pneumonia testing manufacturers globally (2016)
Exhibit 55: Strategic success factors of companies in global pneumonia testing market 2016
Exhibit 56: Share of vendors in global pneumonia testing market 2016
Exhibit 57: Regional analysis of key vendors 2016
Exhibit 58: Key highlights of Abbott Molecular
Exhibit 59: Abbott Molecular: Strength assessment
Exhibit 60: Abbott Molecular: Strategy assessment
Exhibit 61: Abbott Molecular: Opportunity assessment
Exhibit 62: Key highlights of bioMérieux
Exhibit 63: bioMérieux: Strength assessment
Exhibit 64: bioMérieux: Strategy assessment
Exhibit 65: bioMérieux: Opportunity assessment
Exhibit 66: Key highlights of BD
Exhibit 67: BD: Strength assessment
Exhibit 68: BD: Strategy assessment
Exhibit 69: BD: Opportunity assessment
Exhibit 70: Key highlights of Roche Molecular Diagnostics
Exhibit 71: Roche Molecular Diagnostics: Strength assessment
Exhibit 72: Roche Molecular Diagnostics: Strategy assessment
Exhibit 73: Roche Molecular Diagnostics: Opportunity assessment
Exhibit 74: Key highlights of Thermo Fisher Scientific
Exhibit 75: Thermo Fisher Scientific: Strength assessment
Exhibit 76: Thermo Fisher Scientific: Strategy assessment
Exhibit 77: Thermo Fisher Scientific: Opportunity assessment
Note: Product cover images may vary from those shown
3 of 5

Loading
LOADING...

4 of 5

FEATURED COMPANIES

  • Abbott Molecular
  • Beckman Coulter
  • Bio-Rad
  • Diamedix
  • Fast-track diagnostics
  • Qiagen
  • MORE
New Report Released: – Global Pneumonia Testing Market 2017-2021

The author of the report recognizes the following companies as the key players in the global pneumonia testing market: Abbott Molecular, bioMérieux, Becton, Dickenson and Company (BD), Roche Molecular Diagnostics, and Thermo Fisher Scientific.

Other Prominent Vendors in the market are: AdvanDx, Alere, Beckman Coulter, Bio-Rad, Cepheid, Concile, Diamedix, DiaSorin, Eiken Chemical, Fast-track diagnostics, Hologic, Meridian Biosciences, Qiagen, Quest Diagnostics, Quidel, SeraCare, and Trinity Biotech.

Commenting on the report, an analyst from the research team said: “One trend in market is increase in adoption of molecular diagnostic testing. Accurate and rapid diagnosis of pneumonia reduces recovery time and healthcare expenditure to a significant extent. Recent advances in molecular diagnostic testing technologies have led to an improvement in the precision, sensitivity, efficiency, and speed of clinical diagnostic procedures. For instance, FilmArray by bioMérieux offers fast, easy, and comprehensive molecular testing technology that integrates sample preparation, amplification, detection, and analysis. The system provides extraction, amplification, and detection in a closed system, which minimizes contamination and provides accurate results. Furthermore, innovations such as automation of immunoassay testing are likely to improve accuracy, speed, and reliability of results, which will also help enhance the popularity and adoption of such tests. Also, vendors are developing products with new and advanced technology to retain their competitive edge in the market. Innovative companies are also developing rapid diagnostic multiplex PCR kits to attract new customer bases, like Fast-track diagnostics' FTD Bacterial pneumoniae_CAP. AdvanDx's PNA FISH molecular-based diagnostic platform is the first of its kind that can detect E. coli/K. pneumoniae/P. aeroginosa from blood cultures directly in hours.”

According to the report, one driver in market is growing popularity of POC testing. POC testing is the new boom in the market because of the decreased time latency between diagnosis and treatment. The advances in POC technology have facilitated data storage, data sharing, and communication with public health agencies. Performing these tests to screen infectious diseases extends the applications of this technology to the community practice setting. For instance, processing accurate data on the prevalence of pneumonia in a community could help restrain inappropriate use of antibiotics and improve the allocation of vaccines to areas with the highest need.

Further, the report states that one challenge in market is limited detection capability and accuracy. Pneumonia testing, especially the rapid diagnostic kit, in many clinical trials has failed to provide accurate results in comparison with detailed testing. One of the prime reasons for this is that pneumonia can be caused either by bacteria, virus, or fungus. Though the assays used to detect bacterial pneumonia can detect almost all the strains of bacteria, it is rare for them to detect pneumonia caused by RSV. For instance, Alere BinaxNOW Streptococcus pneumoniae Antigen Card can detect S. pneumoniae responsible for CAP, but it cannot detect L. pneumophila responsible for atypical pneumonia for which bioMérieux's bioNexia Legionella can be used. Hence, it becomes difficult for physicians and healthcare professionals to detect pneumonia and its type accurately before proceeding toward its cure. Due to the limited lifespan of biomolecules, vendors fail to develop rapid diagnostic kits that can offer a high degree of accuracy and withstand the stress associated with environmental changes. Available technologies also may be responsible for decreased sensitivity latest PCR technology has higher sensitivity than older techniques like Western Blotting. Hence the inefficiency of these tests to detect pneumonia accurately and at one go, hinder their market growth significantly.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Note: Product cover images may vary from those shown
5 of 5
  • Abbott Molecular
  • bioMérieux
  • Becton
  • Dickenson and Company (BD)
  • Roche Molecular Diagnostics
  • Thermo Fisher Scientific
  • AdvanDx
  • Alere
  • Beckman Coulter
  • Bio-Rad
  • Cepheid
  • Concile
  • Diamedix
  • DiaSorin
  • Eiken Chemical
  • Fast-track diagnostics
  • Hologic
  • Meridian Biosciences
  • Qiagen
  • Quest Diagnostics
  • Quidel
  • SeraCare
  • Trinity Biotech
Note: Product cover images may vary from those shown
6 of 5
Note: Product cover images may vary from those shown
Adroll
adroll